Kobanawa M, Iwami N, Hanaoka M, Enatsu K, Ichiyama T
Cureus. 2025; 16(12):e76371.
PMID: 39867102
PMC: 11759662.
DOI: 10.7759/cureus.76371.
Schouten N, Wang R, Torrance H, Van Tilborg T, Bastu E, Bergh C
Hum Reprod Update. 2024; 31(2):116-132.
PMID: 39707165
PMC: 11879166.
DOI: 10.1093/humupd/dmae032.
Capolupo A, Petrocchi S, Melchiorre M, Jonas K, DHooghe T, Hanyaloglu A
Int J Mol Sci. 2024; 25(17).
PMID: 39273352
PMC: 11395176.
DOI: 10.3390/ijms25179405.
Kobanawa M, Yoshida J
Reprod Med Biol. 2024; 23(1):e12586.
PMID: 38827517
PMC: 11140174.
DOI: 10.1002/rmb2.12586.
Huang H, Gao H, Shi Y, Deng B, He X, Lin J
Reprod Biol Endocrinol. 2023; 21(1):121.
PMID: 38110998
PMC: 10726541.
DOI: 10.1186/s12958-023-01173-8.
Does the decrease in E2 levels between the trigger of ovulation and embryo transfer affect the reproductive outcome in IVF-ICSI cycles?.
Yenigul N, Ozelci R, Baser E, Dilbaz S, Aldemir O, Dilbaz B
Turk J Obstet Gynecol. 2023; 20(3):199-205.
PMID: 37667480
PMC: 10478728.
DOI: 10.4274/tjod.galenos.2023.91043.
Dose Nomogram of Individualization of the Initial Follicle-Stimulating Hormone Dosage for Patients with Polycystic Ovary Syndrome Undergoing IVF/ICSI with the GnRH-Ant Protocol: A Retrospective Cohort Study.
Si M, Qi X, Zhen X, Yang C, Tian T, Long X
Adv Ther. 2023; 40(9):3971-3985.
PMID: 37395872
PMC: 10427540.
DOI: 10.1007/s12325-023-02582-2.
Circulating maternal prorenin and oocyte and preimplantation embryo development: the Rotterdam Periconception Cohort.
Wiegel R, Danser A, van Duijn L, Willemsen S, Laven J, Steegers E
Hum Reprod. 2023; 38(4):582-595.
PMID: 36795035
PMC: 10068267.
DOI: 10.1093/humrep/dead030.
The gonadotropins starting dose calculator, which can be adjusted the target number of oocytes and stimulation duration days to achieve individualized controlled ovarian stimulation in Japanese patients.
Kobanawa M
Reprod Med Biol. 2023; 22(1):e12499.
PMID: 36699956
PMC: 9853467.
DOI: 10.1002/rmb2.12499.
Prediction model of gonadotropin starting dose and its clinical application in controlled ovarian stimulation.
Hua L, Zhe Y, Jing Y, Fujin S, Jiao C, Liu L
BMC Pregnancy Childbirth. 2022; 22(1):810.
PMID: 36333671
PMC: 9635211.
DOI: 10.1186/s12884-022-05152-6.
A Novel Nomogram for Individualized Gonadotropin Starting Dose in GnRH Antagonist Protocol.
Li Y, Duan Y, Yuan X, Cai B, Xu Y, Yuan Y
Front Endocrinol (Lausanne). 2021; 12:688654.
PMID: 34594300
PMC: 8476945.
DOI: 10.3389/fendo.2021.688654.
Dual trigger protocol is an effective in vitro fertilization strategy in both normal and high responders without compromising pregnancy outcomes in fresh cycles.
Chung R, Mancuso A, Summers K, Sparks A, Duran H, Mejia R
F S Rep. 2021; 2(3):314-319.
PMID: 34553157
PMC: 8441566.
DOI: 10.1016/j.xfre.2021.05.008.
Can Ratios Between Prognostic Factors Predict the Clinical Pregnancy Rate in an IVF/ICSI Program with a GnRH Agonist-FSH/hMG Protocol? An Assessment of 2421 Embryo Transfers, and a Review of the Literature.
Merviel P, Menard M, Cabry R, Scheffler F, Lourdel E, Le Martelot M
Reprod Sci. 2020; 28(2):495-509.
PMID: 32886340
DOI: 10.1007/s43032-020-00307-2.
Correlation between biochemical, ultrasonographic and demographic parameters with ovarian response to IVF/ICSI treatments in Mexican women.
Vazquez A, Rodriguez J, Algara A, Garcia J
JBRA Assist Reprod. 2020; 25(1):4-9.
PMID: 32489091
PMC: 7863092.
DOI: 10.5935/1518-0557.20200040.
Individualized ovarian stimulation in IVF/ICSI treatment: it is time to stop using high FSH doses in predicted low responders.
Leijdekkers J, Torrance H, Schouten N, van Tilborg T, Oudshoorn S, Mol B
Hum Reprod. 2019; 35(9):1954-1963.
PMID: 31838515
PMC: 7485616.
DOI: 10.1093/humrep/dez184.
A retrospective analysis of the follicle-stimulating hormone starting dose in expected normal responders undergoing their first fertilization cycle: proposed dose versus empiric dose.
Lee D, Han S, Kim S, Jee B
Clin Exp Reprod Med. 2018; 45(4):183-188.
PMID: 30538949
PMC: 6277670.
DOI: 10.5653/cerm.2018.45.4.183.
How to personalize ovarian stimulation in clinical practice.
Sighinolfi G, Grisendi V, La Marca A
J Turk Ger Gynecol Assoc. 2017; 18(3):148-153.
PMID: 28890430
PMC: 5590212.
DOI: 10.4274/jtgga.2017.0058.
Sleep in women undergoing in vitro fertilization: a pilot study.
Goldstein C, Lanham M, Smith Y, OBrien L
Sleep Med. 2017; 32:105-113.
PMID: 28366321
PMC: 5380145.
DOI: 10.1016/j.sleep.2016.12.007.
PIVET rFSH dosing algorithms for individualized controlled ovarian stimulation enables optimized pregnancy productivity rates and avoidance of ovarian hyperstimulation syndrome.
Yovich J, Alsbjerg B, Conceicao J, Hinchliffe P, Keane K
Drug Des Devel Ther. 2016; 10:2561-73.
PMID: 27563236
PMC: 4986677.
DOI: 10.2147/DDDT.S104104.
Nomogram to predict the number of oocytes retrieved in controlled ovarian stimulation.
Moon K, Kim H, Lee J, Lee J, Jee B, Suh C
Clin Exp Reprod Med. 2016; 43(2):112-8.
PMID: 27358830
PMC: 4925866.
DOI: 10.5653/cerm.2016.43.2.112.